The Role of Decongestants, Cromolyn, Guafenesin, Saline Washes, Capsaicin, Leukotriene Antagonists, and Other Treatments on Rhinitis

Immunology and Allergy Clinics of North America

Volumn 31, Issue 3, 2011, Pages 601-617

  Kushnir, Nataliya M ^a  

^a Allergy and Immunology Clinic of East Bay   (United States)

Author keywords

Acupuncture; Allergy; Alternative treatment; Decongestants; Herbal treatment; Leukotriene antagonist; Rhinitis; Saline wash

Indexed keywords

AFRINO; AH CHEW; ANTI TUSS; ARSENIC TRIOXIDE; CAPSAICIN; CETIRIZINE PLUS PSEUDOEPHEDRINE; CHLORHEXIDINE; CHLORTRIMETON NASAL DECONGESTATNT; CLARITIN D; CONTAC COLD; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DESPEC SF; DIME; DIMETTAP; DRISTAN; DRIXORAL DECONGESTANT; ELTOR; EPHEDRINE; FOUR WAY NASAL SPRAY; GUAIFENESIN; GUAIFENESIN LA; GUAIFENESIN PLUS PSEUDOEPHEDRINE; HERBACEOUS AGENT; HUMIBID LA; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIQUIMIB; LUSONAL; METHANOL; MUCINEX FULL FORCE; MUCO FEN 1200; MUCO FEN 800; MUCO FEN LA; NALDECON EX SENIOR; NASOP; NASOP12; NON PRESCRIPTION DRUG; NOREPHEDRINE; NRS NASAL; NTZ LONG ACTING NASAL; NUX VOMICA; ONION EXTRACT; OXYFRIN; OXYMETA 12; OXYMETAZOLINE; PEDIACARE CHILDREN DECONGESTANT; PETASITES HYBRIDUS EXTRACT; PHENYL T; PHENYLEPHRINE; PLACEBO; PSEUDOEPHEDRINE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; Q BID LA; SHO SEIRYU TO; SI; SINAREST NASAL; SODIUM CHLORIDE; SUDAFED OM; SUDAFED PE; SUDAFED PE EXTRA STRENGTH; SUDOGEST PE; TRIAMINIC; TRIAMINIC THIN STRIPS COLD; UNCLASSIFIED DRUG; ZYRTEC D;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ADD ON THERAPY; ADJUVANT THERAPY; ALLERGIC RHINITIS; ANXIETY; APPLICATION SITE BURNING; ASTHMA; AUDITORY TUBE DYSFUNCTION; BACTERIAL SINUSITIS; BRONCHITIS; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC RHINITIS; CHRONIC SINUSITIS; COMBINATION CHEMOTHERAPY; COMMON COLD; COUGHING; DIZZINESS; DRUG APPROVAL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRY NOSE; EPIPHORA; EXCITABILITY; FOOD AND DRUG ADMINISTRATION; HAND TREMOR; HEART ARRHYTHMIA; HEART INFARCTION; HEART PALPITATION; HOMEOPATHY; HUMAN; HYPERTENSION; INJECTION SITE STINGING; MONOTHERAPY; NASAL LAVAGE; NASAL PRURITUS; NAUSEA; NERVOUSNESS; NOSE CONGESTION; OTITIS MEDIA; PATIENT ATTITUDE; PATIENT SATISFACTION; PHYTOCHEMISTRY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINITIS MEDICAMENTOSA; RHINORRHEA; RHINOSINUSITIS; SIDE EFFECT; SINUSITIS; SLEEP DISORDER; SNEEZING; SOMNOLENCE; STROKE; SWEATING; TACHYCARDIA; TASTE DISORDER; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VASOMOTOR RHINITIS; VIRAL RHINOSINUSITIS; VIRUS INFECTION; VOMITING; WEAKNESS;

CAPSAICIN; COMPLEMENTARY THERAPIES; CROMOLYN SODIUM; GUAIFENESIN; HUMANS; LEUKOTRIENE ANTAGONISTS; NASAL DECONGESTANTS; NASAL LAVAGE FLUID; RHINITIS; SODIUM CHLORIDE;

EID: 79959942943     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2011.05.008     Document Type: Review

References (69)

1. Dykewicz M.S., Fineman S., Skoner D.P., et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998, 81:478.
2. Bachert C. Persistent rhinitis - allergic or nonallergic?. Allergy 2004, 59(Suppl 76):11.
3. Novak N., Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003, 112:252.
4. Quan M., Casale T.B., Blaiss M.S. Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts. Clin Cornerstone 2009, 9:54.
5. Meltzer E.O., Nathan R.A., Derebery J., et al. Physician perceptions of the treatment and management of allergic and nonallergic rhinitis. Allergy Asthma Proc 2009, 30:75.
6. Marple B.F., Fornadley J.A., Patel A.A., et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007, 136:S107.
7. Lockey R.F. Rhinitis medicamentosa and the stuffy nose. J Allergy Clin Immunol 2006, 118:1017.
8. Simons F.E. Chronic rhinitis. Pediatr Clin North Am 1984, 31:801.
9. Keyserling H.F., Grimme J.D., Camacho D.L., et al. Nasal septal perforation secondary to rhinitis medicamentosa. Ear Nose Throat J 2006, 85:376.
10. Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Ann Allergy Asthma Immunol 2004, 93:S45.
11. Corey J.P., Houser S.M., Ng B.A. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J 2000, 79:690.
12. Scarupa M.D., Kaliner M.A. Adjuvant therapies in the treatment of acute and chronic rhinosinusitis. Clin Allergy Immunol 2007, 20:251.
13. Johnson D.A., Hricik J.G. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy 1993, 13:110S.
14. Kushnir N.M. Rhinitis medicamentosa Available at:, Accessed October 13, 2009. http://emedicine.medscape.com/article/995056-overview:medscape.
15. Hatton R.C., Winterstein A.G., McKelvey R.P., et al. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother 2007, 41:381.
16. Kanfer I., Dowse R., Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993, 13:116S.
17. Burton B.T., Rice M., Schmertzler L.E. Atrioventricular block following overdose of decongestant cold medication. J Emerg Med 1985, 2:415.
18. Escobar J.I., Karno M. Chronic hallucinosis from nasal drops. JAMA 1859, 247:1982.
19. Hass D.J., Kozuch P., Brandt L.J. Pharmacologically mediated colon ischemia. Am J Gastroenterol 2007, 102:1765.
20. Olivier P., Dugue A., Montastruc J.L. Therapie 2003, 58:361. [in French].
21. Demoly P., Piette V., Daures J.P. Treatment of allergic rhinitis during pregnancy. Drugs 1813, 63:2003.
22. Using over-the-counter cough and cold products in children Available at:, Accessed October 22, 2008. http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/ucm048524.pdf.
23. Dart R.C., Paul I.M., Bond G.R., et al. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med 2009, 53:411.
24. Vernacchio L., Kelly J.P., Kaufman D.W., et al. Pseudoephedrine use among US children, 1999-2006: results from the Slone Survey. Pediatrics 2008, 122:1299.
25. Reynolds E.B. Martindale: the complete drug reference 1989, Pharmaceutical Press, London.
26. Kobayashi S., Endou M., Sakuraya F., et al. The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release?. Anesth Analg 2003, 97:1239.
27. Ralston S., Roohi M. A randomized, controlled trial of nasal phenylephrine in infants hospitalized for bronchiolitis. J Pediatr 2008, 153:795.
28. Corboz M.R., Rivelli M.A., Varty L., et al. Pharmacological characterization of postjunctional alpha-adrenoceptors in human nasal mucosa. Am J Rhinol 2005, 19:495.
29. Graf P. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology 1996, 34:9.
30. Storms W., Farrar J.R. Guaifenesin in rhinitis. Curr Allergy Asthma Rep 2009, 9:101.
31. Kuhn J.J., Hendley J.O., Adams K.F., et al. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest 1982, 82:713.
32. Wawrose S.F., Tami T.A., Amoils C.P. The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus (HIV). Laryngoscope 1992, 102:1225.
33. Peters-Golden M., Gleason M.M., Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 2006, 36:689.
34. Ohnishi H., Miyahara N., Gelfand E.W. The role of leukotriene B(4) in allergic diseases. Allergol Int 2008, 57:291.
35. Piatti G., Ceriotti L., Cavallaro G., et al. Effects of zafirlukast on bronchial asthma and allergic rhinitis. Pharmacol Res 2003, 47:541.
36. Lagos J.A., Marshall G.D. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag 2007, 3:327.
37. Sardana N., Santos C., Lehman E., et al. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score. Allergy Asthma Proc 2010, 31:5.
38. Cingi C., Gunhan K., Gage-White L., et al. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis. Laryngoscope 2010, 120(9):1718-1723.
39. Phan H., Moeller M.L., Nahata M.C. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast. Drugs 2009, 69:2541.
40. Storms W., Kaliner M.A. Cromolyn sodium: fitting an old friend into current asthma treatment. J Asthma 2005, 42:79.
41. Henderson W.R., Kaliner M. Mast cell granule peroxidase: location, secretion, and SRS-A inactivation. J Immunol 1979, 122:1322.
42. Long A., McFadden C., DeVine D., et al. Management of allergic and nonallergic rhinitis. Evid Rep Technol Assess (Summ) 2002, (54):1-6.
43. Meltzer E.O. Allergic rhinitis: managing the pediatric spectrum. Allergy Asthma Proc 2006, 27:2.
44. Greiner A.N., Meltzer E.O. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 2006, 118:985.
45. Meltzer E.O. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study. Clin Ther 2002, 24:942.
46. Papsin B., McTavish A. Saline nasal irrigation: its role as an adjunct treatment. Can Fam Physician 2003, 49:168.
47. Slapak I., Skoupa J., Strnad P., et al. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 2008, 134:67.
48. Govindarajan V.S. Capsicum-production, technology, chemistry, and quality. Part III. Chemistry of the color, aroma, and pungency stimuli. Crit Rev Food Sci Nutr 1986, 24:245.
49. Bascom R., Kagey-Sobotka A., Proud D. Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther 1991, 259:1323.
50. Marabini S., Ciabatti P.G., Polli G., et al. Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhinolaryngol 1991, 248:191.
51. Blom H.M., Severijnen L.A., Van Rijswijk J.B., et al. The long-term effects of capsaicin aqueous spray on the nasal mucosa. Clin Exp Allergy 1998, 28:1351.
52. Ciabatti P.G., D'Ascanio L. Intranasal capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial. Acta Otolaryngol 2009, 129:367.
53. Sanico A.M., Atsuta S., Proud D., et al. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997, 100:632.
54. Van Rijswijk J.B., Boeke E.L., Keizer J.M., et al. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy 2003, 58:754.
55. Lacroix J.S., Buvelot J.M., Polla B.S., et al. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy 1991, 21:595.
56. Eccles R. Menthol: effects on nasal sensation of airflow and the drive to breathe. Curr Allergy Asthma Rep 2003, 3:210.
57. Lee D.K., Carstairs I.J., Haggart K., et al. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy 2003, 33:882.
58. Rehman J., Dillow J.M., Carter S.M., et al. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunol Lett 1999, 68:391.
59. Weber R.W. Stinging nettle. Ann Allergy Asthma Immunol 2003, 90:A6.
60. Tanaka A., Ohashi Y., Kakinoki Y., et al. The herbal medticine shoseiryu-to inhibits allergen-induced synthesis of tumour necrosis factor alpha by peripheral blood mononuclear cells in patients with perennial allergic rhinitis. Acta Otolaryngol Suppl 1998, 538:118.
61. Das A.K., Mizuguchi H., Kodama M., et al. Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats. Allergol Int 2009, 58:81.
62. Brinkhaus B., Witt C.M., Jena S., et al. Acupuncture in patients with allergic rhinitis: a pragmatic randomized trial. Ann Allergy Asthma Immunol 2008, 101:535.
63. Fleckenstein J., Raab C., Gleditsch J., et al. Impact of acupuncture on vasomotor rhinitis: a randomized placebo-controlled pilot study. J Altern Complement Med 2009, 15:391.
64. Jindal V., Ge A., Mansky P.J. Safety and efficacy of acupuncture in children: a review of the evidence. J Pediatr Hematol Oncol 2008, 30:431.
65. Kim J.I., Lee M.S., Jung S.Y., et al. Acupuncture for persistent allergic rhinitis: a multi-centre, randomised, controlled trial protocol. Trials 2009, 10:54.
66. Kong J.C., Lee M.S., Shin B.C. Randomized clinical trials on acupuncture in Korean literature: a systematic review. Evid Based Complement Alternat Med 2009, 6:41.
67. Witt C.M., Pach D., Brinkhaus B., et al. Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forsch Komplementmed 2009, 16:91.
68. Witt C.M., Brinkhaus B. Efficacy, effectiveness and cost-effectiveness of acupuncture for allergic rhinitis - an overview about previous and ongoing studies. Auton Neurosci 2010, 157(1-2):42-45.
69. Frei T., Gassner E. Trends in prevalence of allergic rhinitis and correlation with pollen counts in Switzerland. Int J Biometeorol 2008, 52:841.